It's an interesting idea. I see no reason why we couldn't do that. We certainly recognize that not all the science we're interested in resides within Bayer; we must partner. We do partner with research institutions in Canada, but not to the degree we should, unfortunately. When it comes to North America, the vast majority of the dollars flow to the U.S., and there's absolutely no reason why we are not investing more heavily in Canada. We tend to internalize the development side, and there's absolutely no reason why we could not do more work externally on the development of our innovations for the marketplace.
On April 30th, 2018. See this statement in context.